ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Brazilian court strips Gilead of its patent for Hepatitis C drug Sovaldi
September 30, 2018A judge from the 21st Federalist Court of Brasilia has ruled to invalidate US biopharma company Gilead’s exclusivity patent for Sovaldi (sofosbuvir), which is indicated for Hepatitis C. -
Gilead to release generic versions of hep C meds over a decade before patent expiry
September 29, 2018Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of hepatitis C, Epclusa (sofosbuvir/velpatasvir)... -
FDA approves new indications for Harvoni and Sovaldi
April 11, 2017First HCV direct-acting antivirals approved for use in adolescents.
Pharma Sources Insight January 2025
